Zdrowie i gospodarka · 10/03/2026
FDA Releases Revised Draft Guidance on Biosimilar Development and BPCI Act
The FDA has released a revised draft guidance for industry on biosimilar development and the Biologics Price Competition and Innovation Act, replacing the previous version issued in 2021.